IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.37B
1-Year Est. Return 69.45%
This Quarter Est. Return
1 Year Est. Return
+69.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$168M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1
+$26.9M
2
+$26.3M
3
+$23.5M
4
LLY icon
Eli Lilly
LLY
+$19.5M
5
CRL icon
Charles River Laboratories
CRL
+$17.4M

Top Sells

1
+$19.6M
2
+$15.6M
3
+$12.8M
4
KRYS icon
Krystal Biotech
KRYS
+$10.8M
5
BSX icon
Boston Scientific
BSX
+$10.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS icon
51
Exact Sciences
EXAS
$12.7B
$5.31M 0.49%
+100,000
WAT icon
52
Waters Corp
WAT
$22.6B
$5.24M 0.48%
15,000
-5,000
GKOS icon
53
Glaukos
GKOS
$5.17B
$5.16M 0.47%
+50,000
ELAN icon
54
Elanco Animal Health
ELAN
$10.5B
$5M 0.46%
+350,000
COO icon
55
Cooper Companies
COO
$14.3B
$4.98M 0.46%
+70,000
CRSP icon
56
CRISPR Therapeutics
CRSP
$5.01B
$4.86M 0.45%
100,000
-50,000
TARA icon
57
Protara Therapeutics
TARA
$213M
$4.24M 0.39%
1,400,000
BHVN icon
58
Biohaven
BHVN
$1.1B
$4.23M 0.39%
300,000
+125,000
SANA icon
59
Sana Biotechnology
SANA
$1.06B
$4.09M 0.37%
1,500,000
-500,000
RARE icon
60
Ultragenyx Pharmaceutical
RARE
$3.19B
$3.64M 0.33%
+100,000
SRRK icon
61
Scholar Rock
SRRK
$3.6B
$3.54M 0.32%
100,000
-25,000
NRIX icon
62
Nurix Therapeutics
NRIX
$1.3B
$3.53M 0.32%
310,000
+35,000
JSPR icon
63
Jasper Therapeutics
JSPR
$47M
$3.27M 0.3%
590,000
+15,000
CPRX icon
64
Catalyst Pharmaceutical
CPRX
$2.85B
$3.25M 0.3%
150,000
ALKS icon
65
Alkermes
ALKS
$4.8B
$2.86M 0.26%
100,000
-50,000
TERN icon
66
Terns Pharmaceuticals
TERN
$2.03B
$2.61M 0.24%
700,000
RCUS icon
67
Arcus Biosciences
RCUS
$2.48B
$2.44M 0.22%
+300,000
OSCR icon
68
Oscar Health
OSCR
$4B
$2.14M 0.2%
100,000
-100,000
TENX icon
69
Tenax Therapeutics
TENX
$32.4M
$962K 0.09%
167,000
ANRO icon
70
Alto Neuroscience
ANRO
$376M
$880K 0.08%
400,000
ARWR icon
71
Arrowhead Research
ARWR
$5.7B
– –
-175,000
ASND icon
72
Ascendis Pharma
ASND
$12.5B
– –
-100,000
BBIO icon
73
BridgeBio Pharma
BBIO
$12.8B
– –
-100,000
BDX icon
74
Becton Dickinson
BDX
$55.3B
– –
-20,000
DYN icon
75
Dyne Therapeutics
DYN
$2.68B
– –
-450,000
1 2
3
4